Open AccessLapatinib plus Letrozole as First‐Line Therapy for HER‐2 + Hormone Receptor–Positive Metastatic Breast Cancer
Author(s) -
Schwarzberg Lee S.,
Franco Sandra X.,
Florance Allison,
O'Rourke Lisa,
Maltzman Julie,
Johnston Stephen
Publication year - 2010
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2009-0240erratum
Subject(s) - lapatinib , medicine , metastatic breast cancer , letrozole , oncology , hormone receptor , breast cancer , hormone therapy , cancer , tamoxifen , trastuzumab